Literature DB >> 8449826

Aberrant expression of the p53 tumor suppressor gene in adult T-cell leukemia and HTLV-I-infected cells.

K Yamato1, T Oka, M Hiroi, Y Iwahara, S Sugito, N Tsuchida, I Miyoshi.   

Abstract

By immunoprecipitation analysis, enhanced p53 expression was detected in 3 of 4 adult T-cell leukemia (ATL) cell lines, 1 of 3 HTLV-I-infected cell lines and 1 of 5 fresh ATL samples, compared with phytohemagglutinin-stimulated peripheral blood lymphocytes. Among these 5 high expressers, p53 missense mutations were indicated in 2 ATL cell lines and 1 fresh ATL sample by extensive p53 cDNA and genomic DNA polymerase chain reaction single-strand conformation polymorphism analysis. No mutation was found throughout the entire coding region of the remaining 2 high expressers (1 ATL and 1 HTLV-I-infected cell lines) and low expressers of p53 (2 HTLV-I-infected cell lines). Tax oncoprotein expression was found in these 2 high p53 expressers in which p53 mutation was not present, but not in low p53 expressers or cells carrying this mutation. The levels of p53 mRNA were similar among the samples regardless of p53 levels. Posttranscriptional mechanisms other than missense mutation would thus appear to increase p53 in the Tax-expressing cells but not in cells containing undetectable levels of Tax. No complex formation between p53 and Tax was observed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8449826      PMCID: PMC5919025          DOI: 10.1111/j.1349-7006.1993.tb02775.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  22 in total

1.  The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines.

Authors:  M Scheffner; K Münger; J C Byrne; P M Howley
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

2.  Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression.

Authors:  L Banks; G Matlashewski; L Crawford
Journal:  Eur J Biochem       Date:  1986-09-15

3.  Most human squamous cell carcinomas in the oral cavity contain mutated p53 tumor-suppressor genes.

Authors:  E Sakai; N Tsuchida
Journal:  Oncogene       Date:  1992-05       Impact factor: 9.867

4.  Production of a recombinant human T-cell leukemia virus type-I trans-activator (tax1) antigen and its utilization for generation of monoclonal antibodies against various epitopes on the tax1 antigen.

Authors:  Y Tanaka; A Yoshida; H Tozawa; H Shida; H Nyunoya; K Shimotohno
Journal:  Int J Cancer       Date:  1991-06-19       Impact factor: 7.396

Review 5.  The p53 tumour suppressor gene.

Authors:  A J Levine; J Momand; C A Finlay
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

6.  Transformation to continuous growth of primary human T lymphocytes by human T-cell leukemia virus type I X-region genes transduced by a Herpesvirus saimiri vector.

Authors:  R Grassmann; C Dengler; I Müller-Fleckenstein; B Fleckenstein; K McGuire; M C Dokhelar; J G Sodroski; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

7.  Establishment and characterization of 10 cell lines derived from patients with adult T-cell leukemia.

Authors:  H Hoshino; H Esumi; M Miwa; M Shimoyama; K Minato; K Tobinai; M Hirose; S Watanabe; N Inada; K Kinoshita; S Kamihira; M Ichimaru; T Sugimura
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

8.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.

Authors:  B J Poiesz; F W Ruscetti; A F Gazdar; P A Bunn; J D Minna; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

9.  Human p53 cellular tumor antigen: cDNA sequence and expression in COS cells.

Authors:  R Zakut-Houri; B Bienz-Tadmor; D Givol; M Oren
Journal:  EMBO J       Date:  1985-05       Impact factor: 11.598

10.  Genetic alteration of p53 in some patients with adult T-cell leukemia.

Authors:  H Nagai; T Kinoshita; J Imamura; Y Murakami; K Hayashi; K Mukai; S Ikeda; K Tobinai; H Saito; M Shimoyama
Journal:  Jpn J Cancer Res       Date:  1991-12
View more
  15 in total

1.  Inhibition of p53 transactivation function by the human T-cell lymphotropic virus type 1 Tax protein.

Authors:  C A Pise-Masison; K S Choi; M Radonovich; J Dittmer; S J Kim; J N Brady
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

2.  Differences in the ability of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 tax to inhibit p53 function.

Authors:  R Mahieux; C A Pise-Masison; P F Lambert; C Nicot; L De Marchis; A Gessain; P Green; W Hall; J N Brady
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

Review 3.  Molecular mechanisms of virus-induced carcinogenesis: the interaction of viral factors with cellular tumor suppressor proteins.

Authors:  F Hoppe-Seyler; K Butz
Journal:  J Mol Med (Berl)       Date:  1995-11       Impact factor: 4.599

Review 4.  T-cell control by human T-cell leukemia/lymphoma virus type 1.

Authors:  Genoveffa Franchini; Risaku Fukumoto; Jake R Fullen
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.490

5.  Multi-step aberrant CpG island hyper-methylation is associated with the progression of adult T-cell leukemia/lymphoma.

Authors:  Hiaki Sato; Takashi Oka; Yoko Shinnou; Takami Kondo; Kana Washio; Masayuki Takano; Katsuyoshi Takata; Toshiaki Morito; Xingang Huang; Maiko Tamura; Yuta Kitamura; Nobuya Ohara; Mamoru Ouchida; Koichi Ohshima; Kenji Shimizu; Mitsune Tanimoto; Kiyoshi Takahashi; Masao Matsuoka; Atae Utsunomiya; Tadashi Yoshino
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307

6.  In situ polymerase chain reaction detection of HTLV-I provirus and expression of the p53 tumor suppressor gene in infiltrating cells in skeletal muscle from a patient with adult T cell leukemia.

Authors:  I Higuchi; K Hashimoto; N Kashio; S Izumo; H Matsuoka; M Nakagawa; M Osame
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

7.  Human T-cell lymphotropic/leukemia virus type 1 Tax abrogates p53-induced cell cycle arrest and apoptosis through its CREB/ATF functional domain.

Authors:  J C Mulloy; T Kislyakova; A Cereseto; L Casareto; A LoMonico; J Fullen; M V Lorenzi; A Cara; C Nicot; C Giam; G Franchini
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

8.  A novel alternative splicing isoform of human T-cell leukemia virus type 1 bZIP factor (HBZ-SI) targets distinct subnuclear localization.

Authors:  Ken Murata; Toshihisa Hayashibara; Kazuyuki Sugahara; Akiko Uemura; Taku Yamaguchi; Hitomi Harasawa; Hiroo Hasegawa; Kazuto Tsuruda; Toshiro Okazaki; Takehiko Koji; Takayuki Miyanishi; Yasuaki Yamada; Shimeru Kamihira
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

Review 9.  Tumor Suppressor Inactivation in the Pathogenesis of Adult T-Cell Leukemia.

Authors:  Christophe Nicot
Journal:  J Oncol       Date:  2015-06-10       Impact factor: 4.375

10.  Cotranscriptional Chromatin Remodeling by Small RNA Species: An HTLV-1 Perspective.

Authors:  Nishat Aliya; Saifur Rahman; Zafar K Khan; Pooja Jain
Journal:  Leuk Res Treatment       Date:  2012-02-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.